Pharmaceutical - Mergers & Acquisitions


Current filters:

Mergers & Acquisitions

Popular Filters

226 to 250 of 656 results

New Zealand medicines and vaccines industry bodies merge


Patients in New Zealand could get better access to new and improved vaccines following a merger between…

Mergers & AcquisitionsPharmaceutical

Cubist Pharma signs two acquisition deals in one day


In what must have been a busy day for US drugmaker Cubist Pharmaceuticals (Nasdaq: CBST) announced not…

Antibiotics and Infectious diseasesCubist PharmaceuticalsDificidMergers & AcquisitionsOptimer PharmaceuticalsPharmaceuticaltedizolidTrius Therapeutics

Health care M&A spending grows in 2nd-qtr 2013, says Irving Levin


Health care merger and acquisition activity strengthened in the second quarter of 2013. (View full video:…

BiotechnologyMergers & AcquisitionsPharmaceutical

Pfizer to separate business into three units: will this lead to spin-outs?


Moving in a direction already advocated by several analysts, US pharma behemoth Pfizer (NYSE: PFE) today…

GenericsManagementMergers & AcquisitionsPfizerPharmaceutical

Elan board agrees $8.6 billion takeover bid


US health care company Perrigo (NYSE: PRGO) revealed this morning that Ireland-based drugmaker Elan Corp…

ElanGenericsMergers & AcquisitionsPerrigoPharmaceuticalTysabri

Recordati acquires Tunisian drugmaker


Italian drugmaker Recordati (RC: MI) has singed announces the signature of the agreements covering the…

GenericsMergers & AcquisitionsOpalia PharmaPharmaceuticalRecordati

Elan posts financials, as it explores sale of the company


Ireland-based Elan Corp (NYSE:ELN) today reported its second quarter 2013 financial results, showing…

ElanFinancialMergers & AcquisitionsPharmaceuticalTysabri

EU Commission puts conditions on Baxter's acquisition of Gambro


The European Commission has authorized the proposed $4 billion acquisition of privately-held Swedish…

Baxter InternationalGambroMergers & AcquisitionsPharmaceutical

Ipsen makes acquisition and signs R&D deal with Harvard


French drugmaker Ipsen (Euronext: IPN) has acquired UK life sciences company Syntaxin for an upfront…

EuropeIpsenMergers & AcquisitionsNeurologicalPharmaceuticalSyntaxin

Mitsubishi Tanabe to acquire 60% of Canada's Medicago in $172 million deal


Japanese drug major Mitsubishi Tanabe Pharma (TYO: 4508) has reached agreement to acquire 60% of Canada's…

MedicagoMergers & AcquisitionsMitsubishi TanabePharmaceuticalVaccines

Italy's Chiesi gains rights to uniQure's Glybera


Netherlands-based venture capital backed human gene therapy firm uniQure has signed collaboration agreements…

BiotechnologyChiesi FarmaceuticiGlyberaLicensingMergers & AcquisitionsPharmaceuticaluniQure

Pharmstandard confirms OTC spin-off and in talks to buy Bever Pharma


Russia's largest drugmaker Pharmstandard OJSC (PHST RU) has confirmed that it has initiated steps for…

Bever PharmaceuticalGenericsMergers & AcquisitionsPharmaceuticalPharmstandard

Fresenius gets US FDA warning over Indian plant; divests biotech unit


Germany-based Fresenius Kabi has received a warning letter from the US Food and Drug Administration in…

Fresenius BiotechFresenius KabiMergers & AcquisitionsNeoPharmPharmaceuticalRegulationRemovab

XOMA transfers perindopril franchise rights to Symplmed


California, USA-based XOMA Corp (Nasdaq: XOMA) says it has transferred US development and commercialization…

Cardio-vascularLicensingMergers & AcquisitionsperindoprilPharmaceuticalServierSymplmedXOMA Corp

South Africa's Adcock Ingram confirms takeover bid from CFR Pharma


In what was described as a "cautionary" statement, South Africa's largest drugmaker Adcock Ingram (AIP:…

Adcock IngramCFR PharmaceuticalsGenericsMergers & AcquisitionsPharmaceutical

Pharmstandard may sell its non-Rx business for $2.5 billion; AbbVie Russian plans


Pharmstandard, Russia's largest drug producer, is considering selling its production of non-prescription…

AbbVieEuropeMergers & AcquisitionsPharmaceuticalPharmstandardProductionR-Pharma

Pfizer details final spinoff of Zoetis


US pharma behemoth Pfizer (NYSE: PFE) has announced the final exchange ratio of 0.9898 for the animal…

FinancialMergers & AcquisitionsPharmaceutical

Royalty pulls plug on Elan buy (for now?); analysts' view on what comes next


In the ongoing hostile takeover saga, US private equity firm Royalty Pharma has withdrawn its request…

ElanMergers & AcquisitionsPharmaceuticalRoyalty Pharma

Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site


UK pharma giant GlaxoSmithKline (LSE: GSK) said yesterday (June 18) that it has received an offer for…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalProduction

AOP Orphan spins off stake in Activartis as Elan shareholders vote down acquisition


In the wake of yesterday's shareholders vote against Irish drugmaker Elan Corp's (NYSE: ELN) planned…

ActivartisAOP OrphanElanMergers & AcquisitionsOncologyPharmaceutical

226 to 250 of 656 results

Company Spotlight



Back to top